Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2008;39:384-389
Published online before print December 20, 2007, doi: 10.1161/STROKEAHA.107.493544
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/2/384    most recent
STROKEAHA.107.493544v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bruno, A.
Right arrow Articles by Williams, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bruno, A.
Right arrow Articles by Williams, L. S.
Related Collections
Right arrow Type 2 diabetes
Right arrow Acute Cerebral Infarction
Right arrow Other Stroke Treatment - Medical

(Stroke. 2008;39:384.)
© 2008 American Heart Association, Inc.


Original Contributions

Treatment of Hyperglycemia In Ischemic Stroke (THIS)

A Randomized Pilot Trial

Askiel Bruno, MD; Thomas A. Kent, MD; Bruce M. Coull, MD; Ravi R. Shankar, MD; Chandan Saha, PhD; Kyra J. Becker, MD; Brett M. Kissela, MD Linda S. Williams, MD

From the Department of Neurology (A.B.), Division of Pediatric Endocrinology (R.R.S.), and Division of Biostatistics (C.S.), Indiana University School of Medicine, and the Roudebush Veterans Affairs Medical Center (L.S.W.), Indianapolis, Ind; the Department of Neurology (T.A.K.), Baylor College of Medicine, Houston, Tex; the Department of Neurology (B.M.C.), University of Arizona School of Medicine, Tucson, Ariz; the Department of Neurology (K.J.B.), University of Washington School of Medicine, Seattle, Wash; and the Department of Neurology (B.M.K.), University of Cincinnati School of Medicine, Cincinnati, Ohio.

Correspondence to Askiel Bruno, MD, Department of Neurology, Indiana University School of Medicine, 1050 Wishard Blvd, 6th Floor, Indianapolis, IN 46202. E-mail abruno{at}iupui.edu

Background and Purpose— Hyperglycemia may worsen brain injury during acute cerebral infarction. We tested the feasibility and tolerability of aggressive hyperglycemia correction with intravenous insulin compared with usual care during acute cerebral infarction.

Methods— We conducted a randomized, multicenter, blinded pilot trial for patients with cerebral infarction within 12 hours after onset, a baseline glucose value ≥8.3 mmol/L (≥150 mg/dL), and a National Institutes of Health Stroke Scale score of 3 to 22. Patients were randomized 2:1 to aggressive treatment with continuous intravenous insulin or subcutaneous insulin QID as needed (usual care). Target glucose levels were <7.2 mmol/L (<130 mg/dL) in the aggressive-treatment group and <11.1 mmol/L (<200 mg/dL) in the usual-care group. Glucose was monitored every 1 to 2 hours, and the protocol treatments continued for up to 72 hours. Final clinical outcomes were assessed at 3 months.

Results— We randomized 46 patients (31 to aggressive treatment and 15 to usual care). All patients in the aggressive-treatment group and 11 (73%) in the usual-care group had diabetes (P=0.008). Glucose levels were significantly lower in the aggressive-treatment group throughout protocol treatment (7.4 vs 10.5 mmol/L [133 vs 190 mg/dL], P<0.001). Hypoglycemia <3.3 mmol/L (<60 mg/dL) occurred only in the aggressive-treatment group (11 patients, 35%), 4 (13%) of whom had brief symptoms, including only 1 (3%) neurologic. Final clinical outcomes were nonsignificantly better in the aggressive-treatment group.

Conclusions— The intravenous insulin protocol corrected hyperglycemia during acute cerebral infarction significantly better than usual care without major adverse events and should be investigated in a clinical efficacy trial.


Key Words: brain infarction • diabetes mellitus • hyperglycemia • insulin




This article has been cited by other articles:


Home page
StrokeHome page
J. E. O'Connell, A. J. Hildreth, and C. S. Gray
The Glycemia in Acute Stroke Study
Stroke, July 1, 2009; 40(7): e511 - e511.
[Full Text] [PDF]


Home page
StrokeHome page
B. Fuentes, J. Castillo, E. Cobo, and E. Diez-Tejedor
Response to Letter by O'Connell et al
Stroke, July 1, 2009; 40(7): e512 - e513.
[Full Text] [PDF]


Home page
StrokeHome page
N. D. Kruyt, G. J. Biessels, R. J. de Haan, M. Vermeulen, G. J.E. Rinkel, B. Coert, and Y. B.W.E.M. Roos
Hyperglycemia and Clinical Outcome in Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis
Stroke, June 1, 2009; 40(6): e424 - e430.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. Higgins and K. R. Lees
Advances in Emerging Therapies
Stroke, May 1, 2009; 40(5): e292 - e294.
[Full Text] [PDF]


Home page
CMAJHome page
D. E.G. Griesdale, R. J. de Souza, R. M. van Dam, D. K. Heyland, D. J. Cook, A. Malhotra, R. Dhaliwal, W. R. Henderson, D. R. Chittock, S. Finfer, et al.
Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data
Can. Med. Assoc. J., April 14, 2009; 180(8): 821 - 827.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Y. Poppe, S. R. Majumdar, T. Jeerakathil, W. Ghali, A. M. Buchan, M. D. Hill, and the Canadian Alteplase for Stroke Effectiveness St
Admission Hyperglycemia Predicts a Worse Outcome in Stroke Patients Treated With Intravenous Thrombolysis
Diabetes Care, April 1, 2009; 32(4): 617 - 622.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Fuentes, J. Castillo, B. San Jose, R. Leira, J. Serena, J. Vivancos, A. Davalos, A. G. Nunez, J. Egido, E. Diez-Tejedor, et al.
The Prognostic Value of Capillary Glucose Levels in Acute Stroke: The GLycemia in Acute Stroke (GLIAS) Study
Stroke, February 1, 2009; 40(2): 562 - 568.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Collino, M. Aragno, S. Castiglia, C. Tomasinelli, C. Thiemermann, G. Boccuzzi, and R. Fantozzi
Insulin Reduces Cerebral Ischemia/Reperfusion Injury in the Hippocampus of Diabetic Rats: A Role for Glycogen Synthase Kinase-3{beta}
Diabetes, January 1, 2009; 58(1): 235 - 242.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. S. Wiener, D. C. Wiener, and R. J. Larson
Benefits and Risks of Tight Glucose Control in Critically Ill Adults: A Meta-analysis
JAMA, August 27, 2008; 300(8): 933 - 944.
[Abstract] [Full Text] [PDF]